In 2025, our autologous airway basal stem cell technology received regulatory approval for commercial clinical application within the Boao Lecheng International Medical Tourism Pilot Zone in Hainan.
The therapy is now available for the treatment of:
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Disease (ILD) (including idiopathic pulmonary fibrosis (IPF))
- Bronchiectasis
Join Our Therapy
-
Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Address:
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, China -
Department of Respiratory Medicine, Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine
Address:
No. 197 Ruijin Road, Qionghai City, Hainan Province, China -
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University
Address:
No. 28 Qiaozhong Middle Road, Liwan District, Guangzhou (Datansha Campus) / No.151 Yanjiang West Road, Yuexiu District, Guangzhou (Yanjiang Campus)
Notes
1.The initial consultation and cell sample collection can be completed at either of the locations above.
2. The transplantation of airway basal stem cell will be carried out at Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine.
3.For detailed eligibility assessment, process explanation, and scheduling, please contact our dedicated patient liaison.
For General Inquiries
Email: lusheng@regend.cn
Phone: +86 21 5812 1708
WeChat: Please scan the QR code by WeChat.
